Gilead (NASDAQ: GILD) officer gains 11,090 performance-based shares

Rhea-AI Filing Summary

Mercier Johanna reported acquisition or exercise transactions in this Form 4 filing.

Gilead Sciences executive Johanna Mercier received 11,090 shares of common stock through the vesting of performance share award tranches. These shares relate to awards granted on March 10, 2025 that carried both performance- and service-vesting conditions. After this award, her directly held common stock totals 131,378 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Mercier Johanna

Role Chief Comm & Corp Aff Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	11,090	$0.00	--

Holdings After Transaction: Common Stock — 131,378 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mercier Johanna

(Last) (First) (Middle)

GILEAD SCIENCES, INC.

333 LAKESIDE DRIVE

(Street)

FOSTER CITY CA 94404

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GILEAD SCIENCES, INC. [ GILD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Comm & Corp Aff Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		A(1)		11,090	A	$0	131,378	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2025. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors.

Remarks:

	/s/ Edward S. Son by Power of Attorney for Johanna Mercier	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Gilead Sciences (GILD) report for Johanna Mercier?

Johanna Mercier received 11,090 shares of Gilead common stock through vesting of performance share awards. These shares were granted as equity compensation and did not involve a cash purchase, reflecting the satisfaction of performance and service conditions.

How many Gilead (GILD) shares does Johanna Mercier hold after this transaction?

After the award vests, Johanna Mercier directly holds 131,378 shares of Gilead common stock. This figure reflects the addition of 11,090 vested performance-based shares to her prior holdings, as reported in the insider ownership table.

What type of equity award did the Gilead (GILD) executive receive?

The Gilead executive received specific tranches of performance share awards that converted into 11,090 common shares. These awards required both performance-vesting and service-vesting, with performance goals certified by the board’s Compensation and Talent Committee on the reported date.

When were the performance share awards for the Gilead (GILD) officer originally granted?

The performance share awards underlying the 11,090 vested shares were originally granted on March 10, 2025. Over time, they became eligible to vest after meeting predefined performance targets and service requirements approved by Gilead’s Compensation and Talent Committee.

Did the Gilead (GILD) officer buy these shares on the open market?

No, the officer did not buy these 11,090 shares on the open market. They were issued at no cash cost as part of performance share awards, vesting after performance goals were certified and service-vesting conditions were satisfied.